Initial induction and subsequent reduction of alpha(2u)-globulin in urine and serum of mature male rats after repeated intraperitoneal injections of (anti)estrogen.
The influence of sex (anti)hormones on expression of alpha(2u)-globulin (a2uG) is complex and has not been sufficiently detailed. In order to assess the specificity of sex (anti)hormone action on a2uG expression and the utility of this approach as a sensitive screening method, mature male rats were given daily intraperitoneal injections of 17beta-estradiol (E2), dihydrotestosterone (DHT), tamoxifen (TX) and flutamide (FL) for 5 consecutive days. They were employed as representatives of estrogen, androgen, antiestrogen and antiandrogen categories, respectively. Urinary a2uG was specifically altered with E2 (1 microg/kg/day) and TX (50 mg/kg/day), but not by DHT (1 mg/kg/day) or FL (50 mg/kg/day). E2 and TX temporarily increased urinary a2uG on days 1 or 2, and days 2-4, respectively, followed by a return to the control level, and then a decrease with E2. The reduction in urinary a2uG on day 6 was more pronounced than the drop in serum a2uG. Serum hormone levels, and liver and testis weights were not remarkably altered with any treatment. Another strong xenoestrogen, diethylstilbestrol, also significantly reduced urinary and serum a2uG at 1 mg/kg/day on day 6. However, the other xenoestrogens (100 mg/kg/day of bisphenol A, nonylphenol, and dichlorodiphenyltrichloroethane, and 10 mg/kg/day of dieldrin) and phytoestrogens (10 mg/kg/day of genistein and daidzein) were without any appreciable influence. The results indicate that urinary a2uG is a sensitive indicator of estrogen action in mature male rats, with two different responses, initial induction and subsequent reduction.
Nagahori
H
H
Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd., 1-98, 3-Chome, Kasugade-Naka, Konohana-Ku, Osaka, Japan. nagahori@sc.sumitomo-chem.co.jp
Komai
K
K
Tomigahara
Y
Y
Saito
K
K
Isobe
N
N
Kaneko
H
H
D000510:Alpha-Globulins / Q000096:biosynthesis* / Q000652:urine*; D000818:Animals; D001559:Benzhydryl Compounds; D003634:DDT / Q000633:toxicity; D004026:Dieldrin / Q000633:toxicity; D004054:Diethylstilbestrol / Q000008:administration & dosage / Q000633:toxicity; D013196:Dihydrotestosterone / Q000008:administration & dosage / Q000633:toxicity; D004305:Dose-Response Relationship, Drug; D004797:Enzyme-Linked Immunosorbent Assay; D004958:Estradiol / Q000008:administration & dosage / Q000633:toxicity; D004965:Estrogen Antagonists / Q000008:administration & dosage / Q000633:toxicity*; D005485:Flutamide / Q000008:administration & dosage / Q000633:toxicity; D019833:Genistein / Q000633:toxicity; D007274:Injections, Intraperitoneal; D007529:Isoflavones / Q000633:toxicity; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008297:Male; D009929:Organ Size / Q000187:drug effects; D010084:Oxidation-Reduction; D010636:Phenols / Q000633:toxicity; D051381:Rats; D017207:Rats, Sprague-Dawley; D012680:Sensitivity and Specificity; D013629:Tamoxifen / Q000008:administration & dosage / Q000633:toxicity*; D013737:Testis / Q000187:drug effects / Q000473:pathology; D000098826:Bisphenol A Compounds
D000510:Alpha-Globulins; D001559:Benzhydryl Compounds; D003634:DDT; D004026:Dieldrin; D004054:Diethylstilbestrol; D013196:Dihydrotestosterone; D004958:Estradiol; D004965:Estrogen Antagonists; D005485:Flutamide; D019833:Genistein; D007529:Isoflavones; D010636:Phenols; D013629:Tamoxifen; C025500:alpha(2)-microglobulin; C004742:daidzein; C025256:nonylphenol; C006780:bisphenol A; D000098826:Bisphenol A Compounds